"I try to reassure everyone who has been affected by this disease that CF isn't the end of the world if you don't want it to be."
The experience of living with cystic fibrosis is markedly different today than it was decades ago. Thanks to the discovery of the CF gene, the availability of effective drug therapies and advances in technology, the 30,000 Americans who deal with the disease day in and day out are living longer and fuller lives. In a word, they are thriving.

There is a multitude of organizations working to support the cystic fibrosis community, as well as a variety of tools and information available to help people with CF not just live, but thrive.

Vertex Receives European Approval for KALYDECO™

For more information please visit these links:

http://investors.vrtx.com/releasedetail.cfm?ReleaseID=696069

http://www.marketwatch.com/story/vertex-receives-european-approval-for-kalydecotm-ivacaftor-the-first-medicine-to-treat-the-underlying-cause-of-cystic-fibrosis-in-people-with-a-specific-genetic-mutation-g551d-2012-07-27